The suzetrigine, which only acts on pain neurons, is the first innovation in analgesia in the last 20 years. "It stands out ...

A new study led by researchers at the Harvard Pilgrim Health Care Institute found that a 2019 Medicare opioid safety policy showed initial reductions in opioid prescribing to high-risk populations.

Even under the best of circumstances, remembering to take a daily pill can be a challenge. For someone living with ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The drug, Journavx, or suzetrigine, was approved to treat moderate to severe acute, or short-term, pain in adults. Experts ...

The time nicotine stays in your system depends on how long and how often you’re exposed to it. It also depends on whether you smoked it, chewed it, or inhaled it secondhand. Whenever you smoke ...

Activist short-seller firm Hindenburg Research is calling it quits after an impactful eight-year run in which its reports took on high-profile investors like Carl Icahn and Gautam Adani and helped ...

Jennifer B Higgins has been appointed as the acting USCIS director. She has previously served as the USCIS deputy director and in other leadership positions. USCIS manages immigration benefits in ...

Neurocognitive symptoms in patients on long-term opioid therapy occurred more frequently during treatment than before or after treatment initiation, suggesting a potential temporal association.